NO20083064L - Fremgangsmate for fremstilling av et farmasoytisk mellomprodukt - Google Patents
Fremgangsmate for fremstilling av et farmasoytisk mellomproduktInfo
- Publication number
- NO20083064L NO20083064L NO20083064A NO20083064A NO20083064L NO 20083064 L NO20083064 L NO 20083064L NO 20083064 A NO20083064 A NO 20083064A NO 20083064 A NO20083064 A NO 20083064A NO 20083064 L NO20083064 L NO 20083064L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- enantiomers
- formula
- pharmaceutical intermediate
- levocetirizine
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000012450 pharmaceutical intermediate Substances 0.000 title abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
- ZKLPARSLTMPFCP-OAQYLSRUSA-N 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid Chemical compound C1CN(CCOCC(=O)O)CCN1[C@@H](C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-OAQYLSRUSA-N 0.000 abstract 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 abstract 1
- 206010039897 Sedation Diseases 0.000 abstract 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 229960001803 cetirizine Drugs 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960001508 levocetirizine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0501138A HU227325B1 (en) | 2005-12-08 | 2005-12-08 | Process for the production of an intermediate of (dextro- and levo)- cetirizine |
| PCT/HU2006/000108 WO2007066162A1 (en) | 2005-12-08 | 2006-12-08 | Process for the preparation of a pharmaceutical intermediate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20083064L true NO20083064L (no) | 2008-07-08 |
Family
ID=89986438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20083064A NO20083064L (no) | 2005-12-08 | 2008-07-08 | Fremgangsmate for fremstilling av et farmasoytisk mellomprodukt |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20090018337A1 (de) |
| EP (1) | EP1971585B1 (de) |
| JP (1) | JP2009518378A (de) |
| CN (1) | CN101360727A (de) |
| AT (1) | ATE501131T1 (de) |
| DE (1) | DE602006020624D1 (de) |
| EA (1) | EA014530B1 (de) |
| HU (1) | HU227325B1 (de) |
| NO (1) | NO20083064L (de) |
| UA (1) | UA92770C2 (de) |
| WO (1) | WO2007066162A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7880761B2 (en) | 2005-07-20 | 2011-02-01 | Lab Partners Associates, Inc. | Wireless photographic communication system and method |
| US7783188B2 (en) | 2007-05-29 | 2010-08-24 | Lab Partners Associates, Inc. | System and method for maintaining hot shoe communications between a camera and a wireless device |
| WO2009022327A2 (en) | 2007-08-15 | 2009-02-19 | Chemagis Ltd. | Novel process for preparing highly pure levocetirizine and salts thereof |
| CN103044355A (zh) * | 2011-10-13 | 2013-04-17 | 湖南九典制药有限公司 | 合成左西替利嗪的关键中间体及其制备方法 |
| CN110988163B (zh) * | 2019-11-29 | 2022-04-19 | 重庆华邦胜凯制药有限公司 | 一种hplc法分离测定盐酸左西替利嗪及其基因毒性杂质e的方法 |
| CN111205247B (zh) * | 2020-04-22 | 2020-08-14 | 湖南九典宏阳制药有限公司 | 左旋西替利嗪的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI75816C (fi) * | 1981-02-06 | 1988-08-08 | Ucb Sa | Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid. |
| GB8827391D0 (en) * | 1988-11-23 | 1988-12-29 | Ucb Sa | Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride |
| US20030064995A1 (en) * | 2001-10-03 | 2003-04-03 | Merck Patent Gmbh | Amide and urea derivatives as 5-HT reuptake inhibitors and as5-HT1B/1D ligands |
| IL124195A (en) * | 1998-04-23 | 2000-08-31 | Chemagis Ltd | Process for the preparation of esters of 2-¬4-¬4-chlorophenyl¾phenylmethyl¾-1-piperazinyl¬ethoxy¾acetic acid |
| CZ304892B6 (cs) * | 1999-11-30 | 2015-01-07 | EGIS Gyógyszergyár Rt. | Způsob přípravy {2-[4-(α-fenyl-p-chlorbenzyl)piperazin-1-yl]ethoxy}octové kyseliny a nové meziprodukty |
-
2005
- 2005-12-08 HU HU0501138A patent/HU227325B1/hu not_active IP Right Cessation
-
2006
- 2006-08-12 UA UAA200808850A patent/UA92770C2/ru unknown
- 2006-12-08 EA EA200801505A patent/EA014530B1/ru not_active IP Right Cessation
- 2006-12-08 US US12/096,630 patent/US20090018337A1/en not_active Abandoned
- 2006-12-08 CN CNA2006800455299A patent/CN101360727A/zh active Pending
- 2006-12-08 AT AT06842191T patent/ATE501131T1/de not_active IP Right Cessation
- 2006-12-08 DE DE602006020624T patent/DE602006020624D1/de active Active
- 2006-12-08 EP EP06842191A patent/EP1971585B1/de active Active
- 2006-12-08 WO PCT/HU2006/000108 patent/WO2007066162A1/en not_active Ceased
- 2006-12-08 JP JP2008543922A patent/JP2009518378A/ja not_active Withdrawn
-
2008
- 2008-07-08 NO NO20083064A patent/NO20083064L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE602006020624D1 (de) | 2011-04-21 |
| EP1971585A1 (de) | 2008-09-24 |
| JP2009518378A (ja) | 2009-05-07 |
| EA014530B1 (ru) | 2010-12-30 |
| EA200801505A1 (ru) | 2008-10-30 |
| CN101360727A (zh) | 2009-02-04 |
| HUP0501138A2 (en) | 2007-08-28 |
| HU227325B1 (en) | 2011-03-28 |
| US20090018337A1 (en) | 2009-01-15 |
| HU0501138D0 (en) | 2006-02-28 |
| EP1971585B1 (de) | 2011-03-09 |
| UA92770C2 (ru) | 2010-12-10 |
| ATE501131T1 (de) | 2011-03-15 |
| WO2007066162A1 (en) | 2007-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20083064L (no) | Fremgangsmate for fremstilling av et farmasoytisk mellomprodukt | |
| MY148643A (en) | Solvate and crystalline forms of carbamoyl-cyclohexane derivatives | |
| NO20060110L (no) | Spesifik glukokortikosteroid forbindelse med anti-inflammatorisk aktivitet | |
| MEP53708A (en) | 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl) -n-methyl -amino) -anilino)-1- phenyl-methylene] -6-methoxycarbonyl -2-indolinone -monoethanesulphonate and the use thereof as a pharmaceutical composition | |
| NO20063928L (no) | Substituerte kinolinforbindelser | |
| NO20080789L (no) | 1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid | |
| NO20090229L (no) | 1-[2-(2,4-dimetylfenylsulfanyl-fenyl]-piperazin som en forbindelse med kombinert serotoninreopptak, 5-HT3- og 5HT1A-aktivitet for behandlingen av kognitiv smerte | |
| NO20072605L (no) | Nytt antranilinsyrederivat eller et salt derav | |
| NO20083068L (no) | Optisk aktive karbamater, fremgangsmate for deres fremstilling og anvendelse derav som farmasoytiske mellomprodukter | |
| NO20083114L (no) | Polysykliske indazolderivater som er ERK-inhibitorer | |
| BRPI0514738A (pt) | derivados de amida de 3-fenil-diidropirimido[4,5-d]pirimidinonas, sua fabricação e aplicação como agentes farmacêuticos | |
| CY1110358T1 (el) | Υποκατεστημενα παραγωγα προπενυλ πιπεραζινης ως νεοι αναστολεις της αποακετυλασης ιστονης | |
| US11679093B2 (en) | 2-naphthimidamides, analogues thereof, and methods of treatment using same | |
| BR0306922A (pt) | N-pirazinil-fenilsulfonamidas e seu uso no tratamento de doenças mediadas por quimocina | |
| NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
| MX2010008583A (es) | Novedosos formas cristalinas de acido 4-[4-(2-adamantilcarbamoil)- 5-ter-butil-pirazol-1-il]benzoico. | |
| ATE459603T1 (de) | Pyridinaminosulfonylsubstituierte benzamide als inhibitoren von cytochrom p450 3a4 (cyp3a4) | |
| ATE457302T1 (de) | Aromatische etherderivate als thrombin-hemmer | |
| DE502005008057D1 (de) | Substituierte cyclopenten-verbindungen | |
| NO20082411L (no) | Heterocykliske amidforbindelser og anvendelse derav | |
| WO2008139492A3 (en) | A process for the preparation of highly pure ranolazine base | |
| TW200616952A (en) | Novel crystal form of (3-cyano-1h-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]-methanone, hydrochloride | |
| CO5590934A2 (es) | Procedimiento de preparacion de derivados de equinocandina | |
| NO20075766L (no) | Aminoalkyl-amidometyl-substituerte 2-(4-sulfonylamino)-3-hydroksy-3,4-dihydro-2H-kromen-6-yl-derivater og deres anvendelse som kaliumkanalblokkere | |
| TW200700390A (en) | Metabolites for nk-1 antagonists for emesis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |